This information was received as a part of an extensive mesh litigation submission to medtronic.
The fda was notified of this large complaint receipt.
Due to the volume of complaint information received by medtronic, this resulted in a report beyond the 30 day target.
Concomitant medical product(s): unknown permacol product (lot# unknown).
If information is provided in the future, a supplemental report will be issued.
|
The patient's attorney alleged a deficiency against the device.
Product was used for therapeutic treatment of an incisional hernia and a parastomal hernia.
It was reported that after implant, the patient experienced pain, adhesions, hernia recurrence, fistula, chronically draining wound, and infection.
Post-operative patient treatment included revision surgery, removal of infected mesh, repair of hernias, lysis of adhesions, reversal of ileostomy, and resection of entercolonic fistula.
|